Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Inna Y, Gong"'
Publikováno v:
HemaSphere, Vol 8, Iss 8, Pp n/a-n/a (2024)
Abstract CD19‐directed autologous chimeric antigen receptor T cell (CAR‐T) therapy has transformed the management of relapsed/refractory (R/R) large B cell lymphoma (LBCL). Initially approved in the third line and beyond setting, CAR‐T is now s
Externí odkaz:
https://doaj.org/article/fa8dce07de684230b7c7956c73bd0448
Autor:
Hassan Sheikh, BHSc, Nicole Walczak, BHSc, Haaris Rana, BHSc, Nicholas W.H. Tseng, BSc, Mohammad K. Syed, BHSc, Chris Collier, BHSc, Moemin Rezk, BHSc, Inna Y. Gong, MD, PhD, Nigel S. Tan, MD, Sammy H. Ali, MD, Andrew T. Yan, MD, Varinder K. Randhawa, MD, PhD, Laura Banks, RKin, PhD
Publikováno v:
CJC Open, Vol 6, Iss 2, Pp 454-462 (2024)
Background: Women and racialized minorities continue to be underrepresented in cardiovascular (CV) trial outcomes data, despite comprising a significant global burden of CV disease. This study evaluated the impact of trial characteristics on the temp
Externí odkaz:
https://doaj.org/article/49f0d7e9f581422793fc467d736e0061
Autor:
Inna Y. Gong, Bandar Al-Amro, G. V. Ramesh Prasad, Philip W. Connelly, Rachel M. Wald, Ron Wald, Djeven P. Deva, Howard Leong-Poi, Michelle M. Nash, Weiqiu Yuan, Lakshman Gunaratnam, S. Joseph Kim, Charmaine E. Lok, Kim A. Connelly, Andrew T. Yan
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 20, Iss 1, Pp 1-11 (2018)
Abstract Background Cardiovascular disease is a significant cause of morbidity and mortality in patients with end-stage renal disease (ESRD) and kidney transplant (KT) patients. Compared with left ventricular (LV) ejection fraction (LVEF), LV strain
Externí odkaz:
https://doaj.org/article/77d0174ef592457daee7fef730c044a0
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0204123 (2018)
BACKGROUND:Biomarkers are a key component of precision medicine. However, full clinical integration of biomarkers has been met with challenges, partly attributed to analytical difficulties. It has been shown that biomarker reproducibility is suscepti
Externí odkaz:
https://doaj.org/article/d925d4f45dcc4ec6889e8b1cf6fd76ae
Autor:
Sheldon M. Singh, Payam Yazdan-Ashoori, Inna Y. Gong, Djeven P. Deva, Binita Riya Chacko, Nigel S. Tan, Iqwal Mangat, Tamar Shalmon, Saif Al-Mousawy, Paul Angaran, Andrew T. Yan, Luciano Folador, Laura Jimenez-Juan
Publikováno v:
The International Journal of Cardiovascular Imaging. 37:2259-2267
Left atrial (LA) volume and function (LA ejection fraction, LAEF) have demonstrated prognostic value in various cardiovascular diseases. We investigated the incremental value of LA volume and LAEF as measured by cardiovascular magnetic resonance imag
Autor:
Stephanie H. Read, Matthew C. Cheung, Iliana C. Lega, Inna Y. Gong, Yingbo Na, Lorraine L. Lipscombe
Publikováno v:
Diabetologia. 64:540-551
Contemporary data for the association of diabetes with haematological malignancies are lacking. We evaluated the risk of developing haematological malignancies and subsequent mortality in individuals with diabetes compared with those without diabetes
Autor:
John Riches, Jeffrey I. Zwicker, Halil Yildiz, William A. Wood, Inna Y. Gong, Jerome Razanamahery, Fernando Martín-Moro, Raphaël Lattenist, Rushad Patell, Marie-Christiane Mb Vekemans, Stephen Booth, Bruno Fattizzo, Abi Vijenthira, Lydia Scarfò, Lisa K. Hicks, Ioannis Mantzaris, Gordon Cook, Thomas Andrew Fox, Thomas Chatzikonstantinou
Publikováno v:
Blood
Blood, Vol. 136, no. 25, p. 2881-2892 (2020)
Blood, Vol. 136, no. 25, p. 2881-2892 (2020)
Outcomes for patients with hematologic malignancy infected with COVID-19 have not been aggregated. The objective of this study was to perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for these p
Autor:
Andrew T. Yan, Craig C. Earle, Maureen E. Trudeau, Kelvin K. W. Chan, Inna Y. Gong, Andrea Eisen
Publikováno v:
Breast Cancer Research and Treatment. 181:155-165
Little data exist for comparing cardiac safety and survival outcomes of trastuzumab/pertuzumab or ado-T emtansine (TDM1) in metastatic breast cancer (MBC) patients enrolled in randomized clinical trial (RCT) vs the real-world. This was a retrospectiv
Publikováno v:
American journal of hematology. 97(4)
Autor:
Melanie Lynn Powis, Rinku Sutradhar, Aditi Patrikar, Matthew Cheung, Inna Y. Gong, Abi Vijenthira, Lisa K. Hicks, Drew Wilton, Monika K. Krzyzanowska, Simron Singh
Publikováno v:
Journal of Clinical Oncology. 40:167-167
167 Background: In many jurisdictions patients with new hematological cancers, or those receiving hematopoietic stem cell transplant or immunosuppressive agents, were prioritized for COVID vaccination due to increased risk of infection and death. In